21,000 Diagnoses a Year: Why Aviva's Stella Vnook Wants More Women Writing Biotech Checks
Aviva Ventures' Stella Vnook says post-COVID investors demand clinical-grade proof, women-led startups get less funding — and 21,000 yearly ovarian cancer diagnoses show what's missed.